Congenital Cardiac Surgery — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-26.

Also called: congenital heart surgery, pediatric heart surgery, peds cardiac surgery, CHS. A dedicated ACGME fellowship entered after a full cardiothoracic surgery training pathway, rather than a residency you match into from medical school. Organ system: the heart and great vessels, specifically the malformed hearts children are born with (and, increasingly, the same patients grown up, in adult congenital heart disease).

Subspecialty fellowship of Cardiothoracic Surgery.

The 30-second version

Congenital cardiac surgery is the field that operates on hearts the size of a walnut, the malformed hearts some children are born with, in newborns who weigh a few pounds. A congenital surgeon repairs holes between chambers, switches transposed great arteries, rebuilds obstructed valves and aortas, and stages the multi-operation reconstructions that turn a once-fatal single-ventricle heart into a survivable childhood, often on cardiopulmonary bypass, sometimes with the body cooled and the circulation briefly stopped altogether. It sits at the very end of the longest training pipeline in American medicine: you first become a full cardiothoracic surgeon, then add a 2-year fellowship on top, finishing your first real attending job at a median age of about 37. The trade at the center of the field is the starkest in all of surgery: arguably the highest-meaning operating in medicine, giving a dying newborn a whole life, bought with the longest deferral, the heaviest emotional weight, a small and geographically fixed job market, and pay that actually lags the high-volume adult cardiac surgery you could already do with two fewer years of training.

Quick dashboard (details and sources below)
Training after med school 8–10 years (6–8 yr CT surgery + 2 yr congenital fellowship)
Total from college start ~16–18 years — the longest standard pipeline in US medicine
Training chain Med school (4) → Cardiothoracic Surgery (integrated I-6, or General Surgery + CT) → 2 yr Congenital Cardiac Surgery fellowship
Competitiveness (as a Congenital Cardiac Surgery fellowship) Tiny, self-selecting — ~11–15 programs, ~a dozen–20 fellows/yr; the real bottleneck is surviving the CT pipeline first, not the match itself ⟳
Typical full-time pay ~$630,000 (MGMA congenital/peds cardiac median); new-grad first job ~$450,000 ⟳
Pay vs. parent (CT surgery) A discount, not a premium — below high-volume adult cardiac ($900k–$1.3M+) despite longer training ⟳
Lifestyle ~70+ hrs/week, thin call pools, neonatal/ECMO emergencies — no "livable" escape hatch within the field
Burnout No congenital-specific figure — inherit CT: ~56% burnout/depression symptoms alongside ~83% career satisfaction (STS 2019) ⟳
% women ~6.6% (US/global congenital-specific); ~11% in a 2022 US practice survey — one of the least gender-diverse fields ⟳
DO / IMG accessibility Among the most closed in medicine — sits downstream of the already-gated CT pipeline ⟳

What they actually do

Congenital cardiac surgeons repair the malformed hearts children are born with: ventricular and atrial septal defects (holes between chambers), transposition of the great arteries, tetralogy of Fallot, single-ventricle physiology, obstructed valves, coarctations and aortic arches. They operate on hearts that in a newborn can be the size of a walnut, frequently on cardiopulmonary bypass (the heart-lung machine) and sometimes under deep hypothermic circulatory arrest, where the body is cooled and the circulation stopped so the surgeon can work in a bloodless field. Unlike most adult heart surgery, which is largely re-plumbing coronary arteries and swapping valves, much of this work is reconstructing anatomy that never formed correctly in the first place.1

The defining feature is the combination of extreme technical precision on tiny structures and the emotional weight of holding a baby's life in an operation where a millimeter is the line between a normal childhood and death. It is also, despite the "elite operator" stereotype, profoundly team-dense: safe neonatal heart surgery is impossible without perfusion, pediatric cardiac anesthesia, the cardiac ICU, and cardiology all moving in concert. And it is increasingly a lifelong relationship, since congenital surgeons follow the same patients through staged operations in infancy, re-operations in childhood, and the fast-growing world of adult congenital heart disease (ACHD) as defects that were once uniformly fatal become survivable into adulthood. About 79% of congenital surgeons run a mixed pediatric-plus-adult practice; only ~8% are exclusively pediatric.12

Representative procedures: VSD/ASD repair · tetralogy of Fallot repair · arterial switch for transposition · the staged single-ventricle pathway (Norwood → bidirectional Glenn → Fontan) · coarctation and aortic arch reconstruction · valve repair/replacement and the Ross procedure · ACHD re-operations · neonatal/pediatric ECMO and mechanical circulatory support · heart transplantation in children.1

A day in the life: The day often opens with a single long, high-stakes reconstruction, and a neonatal arterial switch or a Norwood can consume most of it, preceded by early rounds in a cardiac ICU full of critically fragile post-op infants who can decompensate in minutes. Between and after cases come the hardest family conversations in medicine (explaining a staged palliation, a re-operation, or that there is nothing more to do), multidisciplinary conference where surgery, cardiology, and imaging decide whether and how to operate on anatomy no textbook exactly matches, and inpatient management of babies on ventilators, pacing wires, and sometimes ECMO. Call is defined by neonatal emergencies such as a ductal-dependent newborn crashing when the ductus closes, plus post-op bleeding or arrest and ECMO cannulation, none of it on your schedule. Volume per surgeon is low by design: a congenital surgeon may do a few hundred cases a year concentrated at one center, against the higher throughput of adult cardiac, but the low count never becomes a light schedule, because each case is a high-wire act.12

The training path & time to completion

Medical school (4 yrs) → a full cardiothoracic surgery training pathway → 2-year ACGME Congenital Cardiac Surgery fellowship → board-eligible for ABTS subspecialty certification in Congenital Cardiac Surgery. This is the longest standard pipeline in American medicine, because every route requires the entire CT-surgery pathway first, then two more years on top.34

  • You must already be a cardiothoracic surgeon. Entry requires completion of an ACGME-accredited thoracic surgery residency and current, valid ABTS primary thoracic certification (or being on track to it). So before you start congenital training, you are already a board-eligible or board-certified CT surgeon, reached by any of the parent field's routes:34
    • Integrated I-6: 6 years direct from medical school, or
    • Traditional: 5-year general surgery residency + 2–3-year CT fellowship (~7–8 years), or
    • Fast-track "4+3": 4 years general surgery + 3 years CT at one institution (7 years).
  • Fellowship length, and the correction to know: it is now 24 consecutive months (2 years) rather than 1. ACGME mandates the 2-year, single-institution fellowship for anyone who began training on/after July 1, 2023 (the old standard was 12 months, and before ACGME accreditation much of this was a non-standardized apprenticeship). Program leadership has been explicit about why it doubled: one year is not enough to master the full spectrum of neonatal heart surgery when most CT residents get only ~3 months of congenital exposure across a 6-year residency.35 ⟳
  • Case requirements: ABTS mandates roughly 150 major pediatric congenital cases over the two years, with ≥50 as primary surgeon in the first year, a genuinely high bar given how few such cases exist per center.5
  • Board: yes, a distinct ABTS subspecialty certificate in Congenital Cardiac Surgery, earned by passing both a Written (Part I) and an Oral (Part II) exam; the exam process must begin within two years of finishing the fellowship. This is a mature credential: ABTS congenital subspecialty certification began in 2009, with ~188 certificates granted by ~2016 (early on, many via a grandfather/practice track; now overwhelmingly via the fellowship).36
  • How you enter: through the TSDA Congenital Cardiac Surgery Fellowship Match, run via SF Match, a tiny specialty-specific match rather than the NRMP/ERAS system (applications ~mid-year, Match Day ~November). Programs are few. Cleveland Clinic was only about the 12th ACGME-accredited program when it launched in 2020, and the field trains on the order of ~a dozen to 20 fellows per year nationally.78 ⟳
  • Total from the start of college: roughly 16–18 years (4 undergrad + 4 med school + 6–8 CT training + 2 congenital), or 2+ years longer than base CT surgery, which is itself already the longest pipeline in medicine. Median age at fellowship completion in a recent survey of graduating fellows was ~37 (range 33–45), one of the oldest "first real attending job" ages of any field.8

How competitive is it?

As a fellowship, congenital cardiac surgery is not primarily a numbers-game bottleneck the way an I-6 residency seat is, but an endurance-and-self-selection one. The scarce, prized commodities are operative volume during training and a real independent-practice job afterward, not the match seat itself.

The honest picture, and why clean fill-rate tables don't exist:

  • The match is tiny and not reported like the NRMP. With only ~11–15 ACGME-accredited programs producing ~a dozen to 20 fellows a year, there is no published "fill rate / applicants-per-position" table (limited data), by the nature of a match this small run through SF Match rather than the NRMP.78 ⟳
  • The bottleneck is upstream. To even apply, you must first win one of 56 integrated I-6 seats (a near-closed, ~2.0:1, US-MD-dominated funnel; see the parent profile) or finish general surgery and a CT fellowship, become a board-eligible CT surgeon, and only then compete for a handful of congenital slots. The gate is the entire CT-surgery pipeline, not the last two years.9
  • Who enters (2021–22 graduate cohort): pathway mix was traditional general surgery → adult cardiac 43%, integrated I-6 38%, fast-track 4+3 19%, and most arrived with thin pediatric exposure (median ~4 months of peds rotations before fellowship, range 1–10).8

The real "competition," and it's unusual: very few CT surgeons are willing to add two more years for a lower-paying, lower-volume, geographically constrained career, so the field self-selects hard for people who want only this. The hard part is not getting in but the operative-volume lottery inside training (median 8 neonatal cases as primary surgeon during fellowship, range 0–25, which is genuinely variable) and the job market on the far side (below).8 ⟳

Board: ABTS subspecialty certification in Congenital Cardiac Surgery, Written (Part I) + Oral (Part II); first offered in 2009.36

Compensation — the robust version

Here is the fact that reframes the whole field: congenital cardiac surgery pays high-tier surgical money in absolute terms, but at a discount to the rest of cardiac surgery rather than a premium, despite the longest training and the highest per-case complexity in the specialty. Always read these numbers against high-volume adult cardiac, because that's the real comparison a congenital fellowship is competing with: two more years of training to enter a branch that pays less than the adult cardiac you could already do.

National number (limited data: this is a small field and surveys scatter):

  • MGMA subspecialty median for congenital and pediatric cardiac: ~$631,397. For scale within the parent field, the same MGMA cut gives cardiovascular transplant ~$505,404 and general thoracic ~$429,923, while high-volume adult cardiac drives CT surgery's $900k–$1.3M+ top bands and the Doximity thoracic-surgery average is ~$690k. So congenital sits high in absolute terms but is, alongside general thoracic, the lowest-earning major branch of CT surgery.910 ⟳
  • First job (new-grad) median: ~$450,000 (range $80,000–$700,000). Enormous variability, from supervised instructor posts to established assistant-professor jobs (2021–22 graduate survey).8 ⟳
  • Salary.com "pediatric cardiac surgeon" base (2025): avg ~$488,837 (range ~$383,384–$605,131). Base-salary-only, so it runs below all-in MGMA total comp.11 ⟳
  • Crowdsourced aggregators (Comparably, ZipRecruiter, Glassdoor, Payscale) are unreliable for a field this small, because they pool trainees and non-attendings; disregard them for a full-time attending (the same caution the parent profile applies to CT surgery).

Why there's a discount, not a premium. Congenital carries the longest training and the highest per-case technical demand in the field, and still earns below high-volume adult cardiac. The parent profile states it plainly: peds cardiac "carries the longest training and lowest case volume per surgeon (few centers, concentrated caseloads), so despite high per-case complexity, career earnings can lag adult cardiac and the ramp to full practice is the longest of all." The economics are driven by low case volume per surgeon, a small number of centers, and a tight job market, rather than by lack of skill.9

The ROI math, stated squarely. Two extra fellowship years, a median age of 37 at completion, a median debt of ~$179k ($0–$550k), and training pay capped around $80k, entering a field that pays less than the adult cardiac you were already qualified to do. Only 41% of 2021–22 graduates had any savings at fellowship completion. This is, by the field's own literature, the worst financial ROI in cardiac surgery.8

Setting & how you're paid. The employment model is overwhelmingly hospital-employed / academic, concentrated at a small number of high-volume children's hospitals and congenital heart centers. 2021–22 graduates landed as 22.7% instructors, 59.1% assistant/associate professors, and only 9.1% private practice.8 Revenue drivers are the same as the rest of CT surgery, meaning surgical case volume (wRVUs at roughly ~$60/wRVU) plus call, transplant, and ECMO stipends, but constrained by low per-surgeon volume and the regionalization of complex neonatal cases into fewer centers. No congenital-specific wRVU or call-stipend table is published (limited data); inherit the CT-surgery structure from the parent profile.9

The job-market caveat that colors all of it, and diverges from the parent field. Where the broader CT-surgery workforce faces a shortage (HRSA projects a ~31% shortfall by 2035), the congenital sub-niche runs closer to saturation, because complex neonatal volume is finite and regionalized:

  • The 2022 STS Congenital Heart Surgery Practice Survey found >40% of surgeons believe there are too many surgeons in their region, 42% called their caseload "too small," and only 51% called volume "just right."2 ⟳
  • 27.3% of 2021–22 graduates took first jobs in which they cannot practice independently (supervised or junior roles), a direct signal of a tight market where new grads can't immediately get full operative autonomy.8 ⟳
  • A global workforce analysis counts ~718 US congenital cardiac surgeons and notes potential geographic oversupply: two-thirds of US centers sit within 25 miles of another.12 ⟳

Lifestyle

Congenital cardiac surgery inherits the parent field's brutal profile and, if anything, sharpens it. Base CT surgery runs ~70+ hours/week with heavy high-acuity call and low schedule control; congenital adds marathon single cases, a cardiac ICU full of fragile neonates, and emergencies driven by ductal-dependent newborns, post-op arrests, and ECMO, all of it organ- and physiology-timed and never yours.19

The crucial nuance: the low case count does not translate into a livable schedule. A congenital surgeon may do fewer operations than a high-volume adult-cardiac colleague, but each is a high-wire reconstruction, the ICU burden is relentless, and, because centers are few and surgeons per center are few, call pools are thin. You are often one of only 2–4 people in your city who can do the operation, which means the pager doesn't spread across a big group the way it might elsewhere. And unlike the parent field, there is no "general thoracic" livable escape hatch within congenital: the whole field is high-acuity.

Lifestyle rating: 1/5. Among the most demanding lifestyles in all of medicine, on par with or below base adult cardiac. The heaviest toll is also front-loaded onto the uniquely long training years and early practice, with modest relief later by shifting toward ACHD, less-emergent work, administration, or education.

Wellbeing — the part to take seriously

Burnout: no congenital-specific figure exists (limited data), so read the parent signal. The STS 2019 Member Practice Survey (1,069 CT surgeons; Ikonomidis et al., Annals of Thoracic Surgery) found ~55.7% reporting symptoms of burnout or depression, yet ~83.1% satisfied with their career choice. This is the field's defining "hardest but most rewarding" paradox, and congenital inherits it fully.913 ⟳ The trainee cost is real too: a TSRA resident survey found ~60% of CT residents burned out multiple times per month, ~44% feeling down or hopeless in the prior month, and ~26% who would not repeat the residency. For cross-field context, general surgery and critical care sit around ~45% burnout (Medscape 2024).914 ⟳

Emotional load is genuinely distinctive, and the heaviest part of the field.

  • The highs are as high as surgery gets. Taking a blue, dying newborn and giving them a childhood is as close to a miracle as an operation comes, and it's the reason people give their lives to this field.
  • The lows are among the heaviest in medicine. You operate on babies. Mortality is visible and devastating. You sit with families in the worst moments of their lives. And you carry the psychological weight of a field where a technical millimeter is the line between a normal life and death. This emotional weight is a named, defining feature of the field's own literature.8

Would-choose-again: no figure, and no honest way to give one. No publisher has produced a by-specialty would-choose-again number since roughly 2019, and the ~91% that circulates for CT surgeons has no publisher behind it. The nearest measured thing is the TSRA resident survey, where ~26% said they would not repeat the residency.14

Career longevity is the real question. The limiters are the fine-motor technical demand (precision on tiny structures) and the psychological weight, not raw physical throughput. The common late-career move is to shift toward ACHD, less-emergent work, administration, or education while keeping the expertise. Add to that an aging workforce, with a median age of ~52 among practicing congenital surgeons, with ~14.9% planning retirement within five years.2 ⟳

Who's in the field (demographics)

Fellowship-specific breakdowns are sparse (limited data), so the best available are the 2022 STS practice survey, a global workforce analysis, and parent-field reference data.

  • Women: congenital-specific estimates cluster around ~6.6% (US/global workforce analysis) to ~11% (2022 STS US practice survey: 88% male), up from ~7% in 2015 and an older circa-2010 subspecialty estimate of ~5.2%. Real but slow gains, leaving this one of the least gender-diverse fields in medicine. Parent CT surgery is ~8.3% women practicing (AAMC 2021).21215 ⟳
  • DO: no congenital-fellowship-specific figure (limited data). Inherit the parent CT pattern, which is among the most closed in medicine: the I-6 route is near-zero DO (~2–4% of the cohort), the traditional general-surgery→CT-fellowship route ~3% DO. Because congenital sits downstream of that already-gated pipeline, access is at least as narrow.916 ⟳
  • IMG: no congenital-specific figure (limited data). Inherit parent CT: near-zero IMG in I-6, ~18% (IMG + US-IMG combined) in the traditional fellowship route, which is the more realistic (if longer) door.916 ⟳
  • URiM: no congenital-specific data (limited data). Parent CT surgery shows no statistically significant change in Black or Hispanic trainee representation between 2013–2017 and 2018–2022; women and Black trainees remain under-represented relative to medical-school enrollment. Cite parent; verify.9 ⟳

Culture, personality & the online stereotypes

Who gravitates here: the most single-minded, mission-driven corner of an already single-minded field, people who decided, often early and immovably, that they want to fix babies' hearts and are willing to spend ~16–18 years and defer real income into their late 30s to do it. Deep technical perfectionists who find meaning worth almost any cost; many are academically oriented, because nearly all the jobs are academic. The field is widely described, in its own writing and online, as a "calling" or "labor of love," chosen for meaning rather than money or lifestyle. As always, plenty of people in the field don't fit any single mold.

The stereotypes. Community perception rather than fact. Each carries a kernel and an unfair edge, and plenty of people do not fit the mold:

  • "The monks of surgery: pure calling, worst ROI." The online read is that congenital surgeons are the true believers who took the longest, hardest path for the lowest pay-per-year-of-training in high-end surgery. The kernel is real, since the economics genuinely are the worst in cardiac surgery, but it flattens a field many describe as the single most rewarding job in medicine.
  • "Longest training, fewest jobs." A recurring, data-backed community warning that you can finish at 37 and still struggle to find a real congenital job. True enough that the field's own journals published a paper literally titled "too long, too costly, too unpredictable," but online it's often framed more fatalistically than the real (and real) mission warrants.
  • "Elite of the elite / ego." Inherits the CT-surgeon "alpha" caricature. Reframe (same as the parent field): safe neonatal heart surgery is impossible without perfusion, cardiac anesthesia, ICU, and cardiology moving in concert. It is intensely team-dense rather than lone-genius bravado.
  • "You have to be a little bit crazy to sign up for this." Community shorthand for the training length plus emotional weight. The kernel: the sacrifice is real and unusual. The unfair edge: it dismisses that for the right person the meaning genuinely outweighs it.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums the recurring themes are near-unanimous that this is the longest and hardest road in medicine, and that you should only do it if fixing children's hearts is the only thing you can picture. There are frequent, blunt warnings that the job market is small, academic, and unpredictable, and that graduates sometimes take instructor or junior roles or wait for a senior surgeon to retire, because a city only needs 2–4 congenital surgeons. People repeatedly note that pay lags high-volume adult cardiac despite far longer training (the "worst financial ROI in cardiac surgery" line). And cutting the other way, there's sincere testimony that those who do it call it the most meaningful work imaginable. The tone online is unusually reverent for a surgical field: less "grind flex," more "this is a calling, go in with eyes open."

Voices from the field. Paraphrased from public writing, with links to the originals:

  • Nguyen et al., JTCVS (2023), "The journey of becoming a congenital heart surgeon: too long, too costly, too unpredictable", a survey of graduating congenital fellows that is the field's own honest self-critique: median completion age ~37, median debt ~$179k, only ~41% with any savings, highly variable operative experience (median 8 neonatal cases as primary), and a first-job market that was overwhelmingly academic and sometimes non-independent.8
  • Cleveland Clinic ConsultQD, "A New Era of Training for Congenital Cardiac Surgeons". Program leadership explains why training doubled to 24 months: one year isn't enough to master the full spectrum of neonatal heart surgery when most CT residents get only ~3 months of congenital exposure across a 6-year residency, and documents the ~150-case / ≥50-as-primary ABTS requirement.5
  • The 2022 STS Congenital Heart Surgery Practice Survey (Workforce & Training Implications), Ann Thorac Surg (2023), the field's own workforce self-assessment, documenting a small, geographically concentrated, aging workforce and a job market where a plurality feel there are too many surgeons in their region.2
  • Ikonomidis et al., STS 2019 Member Practice Survey (Ann Thorac Surg) states the parent-field paradox directly: ~83% career satisfaction alongside ~56% burnout/depression symptoms, and urges surgeons to recognize warning signs before burnout compromises patient care.13

Why people choose it / why people leave

Why choose it: you get to give dying newborns a whole life, arguably the highest-meaning operating in medicine · elite technical mastery on the most complex anatomy in surgery · lifelong relationships with patients and families across staged operations and into adulthood (ACHD) · a small, tight, mission-driven community · intellectual richness (every heart is anatomically unique).

Why leave or avoid it: the longest training in medicine (~16–18 yrs, attending in your late 30s) with the latest income start · pay that lags high-volume adult cardiac despite the longest pipeline, the worst financial ROI in cardiac surgery · a small, academic, unpredictable job market (few centers, thin openings, sometimes a wait for a retirement) · ~70+ hr weeks, thin call pools, neonatal/ECMO emergencies · the heaviest emotional weight, from operating on babies to visible mortality and devastating family conversations · near-total geographic inflexibility (you go where the centers are).

Best fit if: fixing children's hearts is the only career you can picture and you'll pay any time-cost for it · you have elite fine-motor precision and are energized, not paralyzed, by millimeter-stakes · you can carry the emotional weight of pediatric mortality sustainably · you're comfortable with an academic, single-center career and going where the (few) jobs are · you can financially and personally withstand attending income not arriving until your late 30s.

Not for you if: earning speed, schedule control, or geographic freedom matter most · you have near-term financial or caregiving duties that make a 16–18-year deferral untenable · pediatric death would erode you · you want a large, open job market · you're weighing it against adult cardiac mainly on money (adult cardiac pays more, sooner, with more jobs).

The FLI angle — Congenital Cardiac Surgery for first-gen, low-income & immigrant students

This is, honestly, one of the harder FLI fits in all of medicine, and dressing it up would not help anyone.

Where it fits FLI realities well:

  • Meaning and mission. For a first-gen student driven by service, few fields offer more direct, visible good: you take a dying newborn and give them a life. That’s real.
  • PSLF fits naturally. Nearly all congenital jobs are at academic children's hospitals and 501(c)(3) nonprofits, exactly the qualifying employers, and the long training years at nonprofit institutions can also count toward the 120 qualifying payments, which partially offsets the deferral. (Ground it honestly: most physicians carry ~$200k+ in debt, with congenital fellows' median at ~$179k, and PSLF is paperwork-heavy rather than a guarantee. It also forgives federal loans only. Federal borrowing for medical school has stopped at $200,000 since July 2026 and school costs more than that almost everywhere, so a student starting now graduates with a private loan beside the federal one, nothing forgives it, and its payment is set by the balance rather than by income — which is the slice of the debt that argues hardest against a long deferral into a lower-paying field.)8
  • The ceiling is still high-tier surgical pay (~$630k MGMA congenital/peds cardiac; first jobs ~$450k median), even if it lags adult cardiac.

Risks to name squarely:

  • The longest income deferral in all of medicine. Attending pay at ~37, after 16–18 years, so the whole earnings curve starts later than any other field. For a breadwinner or someone with financial caregiving duties, this is the single heaviest consideration; years of foregone earnings and compounding are a real, quantifiable cost. The field's own literature calls the path "too long, too costly, too unpredictable."8
  • Near-closed entry, twice over. You must first get through the CT-surgery pipeline, whose I-6 route is one of the most US-MD-dominated, research-gated, hardest-to-enter funnels in medicine (near-zero DO/IMG). The traditional general-surgery→CT→congenital route is more DO/IMG-open (~18% IMG, ~3% DO at the CT-fellowship step) but is even longer. Either way it presupposes early mentorship and research access many FLI students never had.916
  • Weak earning speed and weak geographic flexibility: the two levers FLI students most need are both poor here. Pay lags adult cardiac, arrives latest, and the jobs are few and clustered at academic centers, so you can't easily practice near family or in an immigrant community, because you go where the ~15 centers are. This is the opposite of the tele-flexible or practice-anywhere fields.
  • An unpredictable job market. Finishing at 37 does not guarantee a congenital job; ~27% of recent graduates took roles where they couldn't yet practice independently. That uncertainty lands hardest on someone with no family financial safety net.8

Bottom line: congenital cardiac surgery offers unmatched meaning and PSLF-friendly employers, but it asks for the longest financial patience in medicine, entry through one of its most gate-kept pipelines, and acceptance of a small, academic, geographically fixed job market with pay that lags the adult-cardiac alternative. Choose it because fixing children's hearts is the only thing you can picture, rather than as a financial or lifestyle play. If you're drawn to it, get into a congenital OR early, find a congenital-surgeon mentor, and go in clear-eyed about the deferral and the job market.

Sub-subspecialties & fellowships

This is the terminal ABTS subspecialty fellowship. Congenital cardiac surgery is where the training ladder stops, after general surgery and then thoracic surgery.

  • The frontier is adult, not pediatric. Adult congenital heart disease is the field's fastest-growing area, because the children these operations were built for now survive into adulthood and keep needing surgeons.
  • Center choice does what a fellowship would. The case mix at a given program decides what you become expert in, and the number of centers doing this work is small.

Fun facts

  • Congenital cardiac surgery sits at the end of the longest standard training pipeline in American medicine, roughly 16–18 years from the start of college, with a median age of ~37 at first attending job.
  • The fellowship doubled from 12 to 24 months for anyone starting on or after July 1, 2023, because one year wasn't enough to master neonatal heart surgery when most CT residents get only ~3 months of congenital exposure across a 6-year residency.5
  • Surgeons routinely operate on hearts the size of a walnut, sometimes under deep hypothermic circulatory arrest, cooling the body and stopping the circulation entirely to work in a bloodless field.
  • It's one of the few fields where a single operation is often staged across years: the Norwood → Glenn → Fontan pathway rebuilds a single-ventricle heart in three planned operations from infancy onward.
  • The US has only ~700–720 congenital cardiac surgeons, trained through ~11–15 programs graduating on the order of a dozen to 20 fellows a year, one of the smallest formal specialties in medicine.812
  • It's the rare surgical field whose own journals published a candid self-critique of the career path titled "too long, too costly, too unpredictable."8
  • Because defects once uniformly fatal are now survivable into adulthood, congenital surgeons increasingly operate on grown-ups, and adult congenital heart disease (ACHD) is one of the field's fastest-growing frontiers.1

Sources

Footnotes

  1. What congenital surgeons do, representative procedures, day-in-the-life, mixed peds+adult practice (79% mixed, ~8% peds-only), and ACHD growth. Consistent with the cardiothoracic surgery profile on this site; clinical detail corroborated by the 2022 STS Congenital Heart Surgery Practice Survey (below), which is the source for the practice-mix percentages. 2026. ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  2. "Report of the 2022 STS Congenital Heart Surgery Practice Survey" and its Workforce & Training Implications companion, Ann Thorac Surg (2023) — 312 contacted, 201 responded (64.4%), 178 active; median age 52; 88% male / ~11% female (up from 7% in 2015); 79% mixed peds+adult, 8% peds-only; most common volume 100–149 cases/yr, ~¼ do <50 peds cases/yr; 42% say caseload "too small," 51% "just right," >40% believe too many surgeons in their region; 14.9% retiring within 5 yrs. https://www.annalsthoracicsurgery.org/article/S0003-4975(23)01071-8/fulltext ; https://pubmed.ncbi.nlm.nih.gov/36693581/ (2023). ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  3. American Board of Thoracic Surgery — Congenital Cardiac Surgery Certification Pathway: requires a prior ACGME thoracic surgery residency + valid ABTS primary thoracic certification; 24 consecutive months of ACGME congenital fellowship at a single institution (12 months if started before July 1, 2023); Congenital Written (Part I) + Oral (Part II) subspecialty exams; exam process must begin within 2 yrs of fellowship completion. https://www.abts.org/ABTS/Congenital/Congenital_Pathway_1/Certification_Pathway.aspx (accessed 2026). ⟳ ↩ ↩2 ↩3 ↩4 ↩5

  4. Parent CT-surgery training routes (integrated I-6; traditional general surgery + CT fellowship; fast-track 4+3) and ABTS primary certification. See the cardiothoracic surgery profile on this site; TSDA, "CT Surgery Training Pathways" (https://tsda.org/the-tsda/ct-residency-programs/ct-surgery-training-pathways/); ABTS "Pathways to Certification." 2024/2025. ↩ ↩2

  5. Cleveland Clinic ConsultQD, "A New Era of Training for Congenital Cardiac Surgeons" — program director explains the doubling to 24 months (one year insufficient; most CT residents get ~3 months of congenital exposure), and documents the ~150 major pediatric case / ≥50-as-primary-in-year-one ABTS requirement. https://consultqd.clevelandclinic.org/a-new-era-of-training-for-congenital-cardiac-surgeons (accessed 2026). ↩ ↩2 ↩3 ↩4

  6. "Congenital Heart Surgery Subspecialty Certification: How Is It Working? The ABTS Perspective," Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2016/2017) — ABTS congenital subspecialty certification began 2009; ~188 certificates granted by ~2016 (38 via the fellowship pathway, the rest grandfathered/practice-track early on); the overwhelming majority of US congenital surgeons now hold it. https://pubmed.ncbi.nlm.nih.gov/28007068/ (2017). ⟳ ↩ ↩2

  7. TSDA Congenital Cardiac Surgery Fellowship Match — run via SF Match (not the NRMP); participating programs must be ACGME-accredited; sample 2026 cycle rank-list deadline Nov 3 / Match Day Nov 10, 2026. https://tsda.org/the-tsda/congenital-match/ (accessed 2026). ↩ ↩2

  8. Nguyen S. et al., "The journey of becoming a congenital heart surgeon: Too long, too costly, too unpredictable," J Thorac Cardiovasc Surg (2023) — graduates of all 11 approved programs, 2021–2022 (n=22): median age at completion 37 (33–45); pathway mix traditional 43% / I-6 38% / 4+3 19%; median 4 months peds rotation pre-fellowship; median 100 total cases (75–170) and 8 neonatal cases (0–25) as primary surgeon; median debt $179k ($0–$550k), only 41% with savings; first-job median salary $450k ($80k–$700k); ~82% academic titles / ~9% private; 27.3% took jobs where they cannot practice independently. https://pubmed.ncbi.nlm.nih.gov/37385526/ ; https://www.jtcvs.org/article/S0022-5223(23)00535-4/abstract (2023). Corrected 2026-08-17: the FLI section offered PSLF against this field's central financial objection, the deferral, without saying which half of a 2026 borrower's debt it reaches. Federal borrowing for medical school has been capped at $200,000 since July 2026, so the private slice beside it is unforgivable and its payment does not fall with income. The employer-eligibility half of that bullet — nonprofit children's hospitals are qualifying employers — is unchanged and was never in question. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16

  9. Parent-field anchors, as carried on the cardiothoracic surgery profile on this site — MGMA subspecialty medians (congenital/peds cardiac ~$631,397; cardiovascular transplant ~$505,404; general thoracic ~$429,923; adult cardiac drives $900k–$1.3M+); Doximity thoracic-surgery average ~$690k; peds cardiac "longest training and lowest case volume per surgeon … career earnings can lag adult cardiac"; CT ~70+ hr weeks and heavy high-acuity call; ~8.3% women practicing; STS 2019 ~55.7% burnout/depression + ~83.1% satisfaction; CT among least DO/IMG-accessible (I-6 near-zero DO/IMG, traditional fellowship ~18% IMG+US-IMG / ~3% DO); ~31% CT workforce shortfall by 2035 (general CT — the congenital sub-niche runs tighter/oversupplied). Women practicing: AAMC, Active Physicians by Sex and Specialty, 2021, gives thoracic surgery 8.3%; AAMC has not republished that row, and its current release covers only specialties above 2,500 active physicians. DO and IMG shares of the CT pipeline are not published by specialty in the NRMP fellowship report, so those two are unverified. 2026. Corrected 2026-08-17: the I-6 gate was given as "~54 seats" at "~2.4:1", inherited from the parent profile, while [^16] on this same page already cited the 2026 Main Match at 56. NRMP, Results and Data: 2026 Main Residency Match, Table 1, gives integrated thoracic surgery 39 programs, 56 positions offered, 0 unfilled, 110 applicants and 56 matched — 1.96 applicants per position. Its five-year row reads 56, 54, 48, 49, 47, so 54 was the 2025 count. Swept 2026-08-17: the parent cardiothoracic surgery profile carried the older pair when this note was written and now carries 39 programs, 56 positions, 110 applicants and 1.96:1, so the two pages agree. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  10. Physicians Thrive, "Cardiothoracic Surgeon Compensation" (MGMA subspecialty cut) — general thoracic ~$429,923, congenital/peds cardiac ~$631,397, cardiovascular transplant ~$505,404. https://physiciansthrive.com/physician-compensation/cardiothoracic-surgeon/ (2024/2025). ⟳ ↩

  11. Salary.com — Pediatric Cardiac Surgeon Salary (Apr 2025): avg base ~$488,837; range ~$383,384–$605,131 (base-salary-only aggregator, below MGMA total comp). https://www.salary.com/research/salary/hiring/pediatric-cardiac-surgeon-salary (2025). ⟳ On Salary.com: its CompAnalyst benchmark is HR-reported employer survey data blended with job-posting data, not a physician panel. It is base-weighted and so runs low against total-compensation surveys, and it is used here for percentile structure rather than for levels. ↩

  12. Global congenital cardiac workforce analysis — counts ~718 congenital cardiac surgeons in the US (largest in the world, ~11.85 per million children), ~6.6% female, and notes potential geographic oversupply (two-thirds of US centers within 25 miles of another). PMC11228906. https://pmc.ncbi.nlm.nih.gov/articles/PMC11228906 (accessed 2026). ⟳ ↩ ↩2 ↩3

  13. STS 2019 Member Practice Survey (1,069 surgeons; Ikonomidis et al., Annals of Thoracic Surgery) — ~55.7% burnout/depression symptoms alongside ~83.1% career satisfaction. Cardiovascular Business summary. https://cardiovascularbusiness.com/topics/patient-care/cardiothoracic-surgeons-satisfied-careers-risk-burnout-depression-remains (2019/2020). ⟳ ↩ ↩2

  14. Cross-specialty comparisons. Burnout: Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023) puts general surgery and critical care both at 45% against a 49% all-physician average. The primary report is paywalled and returns HTTP 402, so the rows come from two independent relays that agree with each other: Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). No would-choose-again figures are carried: the ~78% overall anchor and the ~91% CT self-report that used to sit here have no publisher behind them, and Medscape stopped publishing the by-specialty table around 2019. The resident figures are the TSRA CT-resident survey (~60% burned out multiple times a month, ~44% down or hopeless, ~26% would not repeat the residency), a self-selected survey of that association's trainees. See also the cardiothoracic surgery profile on this site. ⟳ ↩ ↩2

  15. Women in thoracic surgery — ~8.3% practicing, among the least gender-diverse specialties, with a congenital-specific ~5.2% circa 2010. AAMC, Active Physicians by Sex and Specialty, 2021, https://web.archive.org/web/20250112142220/https://www.aamc.org/data-reports/workforce/data/active-physicians-sex-specialty-2021, which gives thoracic surgery as 4,448 active physicians, 369 of them women, 8.3%. The live AAMC address for that release now returns a 404, so this cites the Internet Archive capture of 2025-01-12. AAMC has not republished that row, and its current release covers only specialties above 2,500 active physicians, so thoracic surgery does not appear in it. In training, ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf, reports 36.0% women in integrated thoracic surgery, far above the practicing figure. ⟳ ↩

  16. DO/IMG accessibility of the parent CT pipeline (NRMP) — I-6 near-zero DO/IMG; traditional CT fellowship matched class ~77% MD, ~18% IMG+US-IMG combined, ~3% DO. NRMP Results & Data 2024/2025 and the Thoracic Surgery MRS Report 2025, as carried on the cardiothoracic surgery profile on this site. On the residency side, NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf, reports integrated thoracic surgery filling 100% of 56 positions with 92.9% US MD seniors, 1.8% DO and 5.4% IMG. The fellowship composition figures have no equivalent published table, so treat them as unverified. ⟳ ↩ ↩2 ↩3

Researched with AI assistance and reviewed by hand. How this site is made